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Mini-Abstract 
The pathogenesis for low-trauma wrist fractures in men is not fully understood. This study 
found that these men have lower bone mineral density at the forearm itself, as well as the hip 
and spine, and has shown that forearm bone mineral density is the best predictor of wrist 
fracture.  
 
 
Abstract 
Purpose/Introduction 
Men with distal forearm fractures have reduced bone density at the lumbar spine and hip 
sites, an increased risk of osteoporosis and a higher incidence of further fractures. The aim of 
this case-control study was to investigate whether or not there is a regional loss of bone 
mineral density (BMD) at the forearm between men with and without distal forearm 
fractures.  
 
Methods 
Sixty-one men with low-trauma distal forearm fracture and 59 age-matched bone healthy 
control subject were recruited. All subjects underwent a DXA scan of forearm, hip and spine, 
biochemical investigations, health questionnaires, SF-36v2 and FRAX. The non-fractured 
arm was investigated in subjects with fracture and both forearms in control subjects. 
 
Results 
BMD was significantly lower at the ultradistal forearm in men with fracture compared to 
control subjects, in both the dominant (mean (SD): 0.386g/cm2 (0.049) versus 0.436g/cm2 
(0.054), p<0.001) and non-dominant arm (mean (SD): 0.387g/cm2 (0.060) versus 0.432g/cm2 
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(0.061), p=0.001). Fracture subjects also had a significantly lower BMD at hip and spine sites 
compared with control subjects. 
Logistic regression analysis showed that the best predictor of forearm fracture was ultradistal 
forearm BMD (OR=0.871 (0.805-0.943), p=0.001), with the likelihood of fracture decreasing 
by 12.9% for every 0.01g/cm2 increase in ultra-distal forearm BMD.   
 
Conclusions 
Men with low-trauma distal forearm fracture have significantly lower regional BMD at the 
ultradistal forearm, which contributes to an increased forearm fracture risk. They also have 
generalised reduction in BMD, so that low-trauma forearm fractures in men should be 
considered as indicator fractures for osteoporosis. 
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Introduction  
 
Male osteoporosis is a common condition resulting in compromised bone strength and 
increased risk of fractures with age. For men over the age of 50 years there is a 1 in 5 lifetime 
risk of fracture and men account for 20-30% of all fractures [1]. Life expectancy is increasing 
at a higher rate for men than for women and based on these demographics an 89% increase in 
hip fractures has been predicted by 2025 [2]. The standardised mortality ratio for all fractures 
compared with age-matched healthy subjects is higher in men than women [3, 4, 5]. Despite 
this there has been less research into male osteoporosis compared with women and male 
osteoporosis continues to be both under-diagnosed and under-treated.  
Factors involved in the pathogenesis of distal forearm fractures in Caucasian men are of 
interest because they are considered an “early and sensitive marker of skeletal fragility” [6]. 
Men who have had a distal forearm fracture have a 2.7 fold and 10.7 fold increased risk for 
hip and vertebral fractures respectively compared with age-matched men who have not 
fractured [7]. In retrospective studies, low areal bone mineral density (BMD) was identified 
at the hip and spine with up to 42% of men with this type of fracture having osteoporosis [8, 
9]. One of those studies found that approximately 50% of men with fractures had secondary 
causes for osteoporosis such as glucocorticoid use [8]. It is possible that varying rates of bone 
loss at different skeletal sites may predispose to particular fracture types. It is not known if 
men with distal forearm fractures have reduced BMD at the distal forearm. It has been 
demonstrated that about 60% of distal forearm fractures occur on the left [8, 10, 11] and it is 
speculated that this may be due to reduced BMD in the non-dominant arm. FRAX is a well-
validated tool for identifying individuals at risk of hip and other major fractures [12, 13]. 
FRAX has not been tested for its ability to identify men at risk of forearm fractures.  
There have been no studies of forearm BMD, health parameters and FRAX in men with distal 
forearm fractures. To address this deficiency we have undertaken a case-control study to 
  4 
 
further investigate these fractures in men. The aim was to test the hypothesis that men with 
low trauma distal fractures have lower regional BMD at the forearm compared to control 
subjects without fracture.  
 
Materials and Methods  
 
Study design and participants 
This investigation is an age-matched case-control study: the pathogenesis of Male distal 
foRearm Fracture study or the Mr F study. Subjects were recruited from one geographical 
area (catchment area of The James Cook University Hospital, Middlesbrough, UK and its 
environs) over a period of 28 months.  
All subjects were Caucasian males 50 years and older as the majority of fractures in men 
under 50 years of age are due to high trauma or assault [8]. Written informed consent was 
obtained from all participants.  
Subjects with low trauma distal forearm fracture (defined as fractures of the distal radius with 
or without fracture of the distal ulna) were identified within six months of their fracture from 
hospital databases. Age-matched control subjects without fracture were identified from the 
patient register of collaborating GP practices, which were from rural as well as urban areas to 
ensure that recruited control subjects were representative of the overall population in the 
catchment area of the hospital.  
Subjects were excluded from participation if: they were unable to provide informed consent, 
were already receiving treatment for osteoporosis (including calcium and vitamin D) or 
received it after the fracture, had known metabolic bone disease. (e.g. Paget’s disease, 
osteomalacia, osteopetrosis, hyperparathyroidism, treated hypogonadism), malignancy or 
fractures due to metastatic disease. Subjects with fracture were also excluded if: the fracture 
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was not united at the time of the study visit, was the result of high energy trauma, road traffic 
accident or assault and if they had sustained bilateral forearm fractures or other major 
fractures at the time of the distal forearm fracture. Control subjects were also excluded if they 
had a history of low trauma fracture at any location (excluding digits) or had sustained a 
fracture in the last six months.  
 
Study questionnaires 
All potential participants were approached by mail and asked to complete a questionnaire, 
which could be returned even if they decided not to take part in the main study, to allow 
insight into differences between participants and non-participants. The baseline questionnaire 
collected the following data: name, date of birth, gender, weight and height (subsequently 
measured using a standard scale and stadiometer when attending for DXA), hand dominance, 
site of fracture (where relevant), mechanism of injury, history of previous fractures, risk 
factors for osteoporosis including current smoking and alcohol intake, medical history and 
medication. BMI was calculated as weight/height2 in kg/m2. Participants completed the 
SF36v2 health survey to provide a profile of functional health and well-being scores as well 
as a physical and mental health summary.  
The 10-year percentage risk of fracture (major and hip) was calculated using the Fracture 
Risk Assessment Tool (FRAX) both with and without inclusion of the lowest femoral neck 
BMD [13]. For subjects with fracture a 'pre-fracture' and 'post-fracture' risk were calculated. 
The need for treatment was then established for all participants using the National 
Osteoporosis Guideline Group (NOGG) clinical guideline for the management of men and 
women at high fracture risk in the UK [14]. Those individuals with a sufficiently high 
fracture risk were seen in clinic and received treatment after completing the study protocol. 
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Biochemical Investigations 
Participants had blood taken to detect abnormalities and look for secondary causes of 
osteoporosis or fracture. Participants with fracture were investigated at a minimum of six 
months following their fracture. Where possible subjects had their blood tests evenly 
distributed throughout the year, but due to the seasonal variation in fracture incidence this 
was not always achieved. All bloods were taken between 8.15am and 9.45am with the patient 
fasting. Two participants did not attend for blood tests. 
The laboratory investigations included: full blood count, urea & electrolytes, bone profile 
(including ionised and albumin adjusted calcium, albumin, inorganic phosphate and alkaline 
phosphatase), liver function tests, ESR, CRP, fasting blood sugar, TSH, PTH, total 25 
hydroxyvitamin D (25OHD), total oestradiol, bioavailable oestradiol, total testosterone and 
bioavailable testosterone. Details of the assays and analysers used are given in Online 
Resource 1. Vitamin D levels were defined as: deficient < 25 nmol/L, insufficient 25-50 
nmol/L and sufficient as > 50 nmol/L [15, 16]. 
 
Dual energy X-ray absorptiometry (DXA) 
All participants underwent a DXA scan to determine BMD at the lumbar spine (L2-L4), 
forearm (ultra distal and distal one third of the radius) and both hips (femoral neck and total 
hip sites). Subjects with fracture had a scan of the non-fractured forearm at three to six 
months after fracture whereas control subjects had both forearms scanned at the time of 
recruitment. At the lumbar spine lateral views for vertebral morphometry were also 
undertaken to assess for vertebral fractures, using the Genant and Wu semi quantitative 
approach to confirm [17-19]. All BMD measurements were performed on the same DXA 
scanner throughout (Lunar Prodigy Advanced, GE Healthcare Lunar, Madison, Wisconsin, 
USA, Version 13.6). To reduce bias the same, independent radiographer carried out all DXA 
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measurements and stability and accuracy were monitored daily using a manufacturer-supplied 
phantom. The coefficient of variation (CV), measured using a local spine phantom, were a 
mean of 1.24% and all were less than 1.5%. All quality assurance checks were well within 
manufacturer’s tolerances throughout the study. T-scores were derived using the 
manufacturer’s reference ranges for males at the lumbar spine and forearm and the 
NHANESIII reference database at the hip sites for males 20-39 years of age. Z-scores were 
also determined. T-scores at the hip sites were further developed using female reference 
databases from NHANESIII in light of the recent recommendations to use femoral neck 
BMD to calculate fracture risk and determine T-scores [20]. Osteoporosis was defined as per 
WHO definition [21] as a T-score ≤ -2.5 SD below the mean for a young person with 
osteopenia being between > -2.5 and < -1.0 SD and normal being ≥ -1. 
 
Sample size calculation 
As no data on BMD at the forearm was available for men, the sample size calculation has 
been based on the difference in BMD at the femoral neck in men with and without distal 
forearm fracture. Using data from Tuck et al. [8] 50 subjects were needed in each group to 
detect a mean difference of 0.103g/cm2 with a standard error of 0.01 and standard deviation 
of 0.1107 in the fracture group and 0.1169 in the control group with a power of 90% at the 
5% significance level. To allow for attrition 60 participants were to be recruited to each 
group. 
 
Statistical analysis 
Statistical analysis was performed using a standard software package (SPSS for Mac, V21). 
All significance tests were two-tailed and carried out at the 5% level. Missing data were not 
replaced. Subject demographic details and outcome measures were summarised by fracture 
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and control group with quantitative variables summarised by the mean, median, standard 
deviation, minimum and maximum and categorical variables summarised by the number of 
subjects and percentage in each category. All quantitative data were tested for normality and 
log transformation performed if data were not normally distributed at initial testing. Data 
were further analysed using paired- and independent t-test for normally distributed data or 
Wilcoxon Rank Sum Test for non-parametric data. Pearson correlation coefficients were 
determined to investigate the relationship between multiple factors and BMD. Values for 
dominant and non-dominant forearm were calculated using data from the available forearm 
from the fracture group with data from all control participants. 
Multiple linear regression analysis using forward selection of variables was performed to 
further examine the association between correlated factors and BMD at all sites. For the 
analysis of BMD at the ultradistal and distal third forearm sites fracture subjects had only one 
set of measurements available, i.e. the non-fractured arm, whereas control subjects had 
measurements at both forearms, i.e. right and left. To allow comparison between all 
participants one value had to be chosen for the control group and the lower value of either 
right or left forearm was selected for each forearm site and compared with the available 
measurement for the fracture group.  
To identify factors that increased the likelihood of fracture in the study cohort, clinically 
relevant factors and factors where there was a significant difference between groups, based 
on t-tests for continuous normally distributed and Mann-Whitney-U test for continuous not 
normally distributed variables, were chosen. A logistic regression model was fitted with 
independent variables using a forward selection method (based on the likelihood ratio test). 
Odd ratios (OR) and confidence intervals were reported. Due to the low magnitude of the 
numerical values for lowest ultradistal forearm BMD when entering them in g/cm2, a new 
variable was created by multiplication with 100 to present a % change per 0.01g/cm2. 
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Results  
Responses 
Figure 1 illustrates the numbers of subjects approached, excluded and agreeing to take part. 
Ultimately, 61 fracture and 59 control subjects were recruited. There was no statistically 
significant difference in age between subjects who took part in the study and subjects who 
did not take part in either the fracture or control group. Subjects who only answered the 
questionnaire were older than subjects who took part in the study (mean age 68.7 and 65.3 
respectively, p=0.015), but there were no statistically significant differences in height, 
weight, health and lifestyle factors. Two participants in the fracture group did not attend for 
blood tests and SF36v2 completion due to difficulties of attending an early morning 
appointment. 
 
Subject characteristics 
There were no significant differences in mean age and anthropometric indices between the 
fracture and control group as shown in Table 1. There was no difference in the proportion of 
fracture cases and control subjects with excess alcohol consumption (> 21 units per week), 
current smoking, prior fragility fractures, pre-existing co-morbidities which could impact on 
bone health or medical conditions. There was a statistically significant difference in the 
physical component score of the SF36v2 between fracture and control participants (p=0.045), 
but no difference in the mental component score (p=0.371) at a minimum of six months 
following the fracture. Although most of the participants in the fracture group were right 
hand dominant (88.5%), subjects were almost equally likely to fracture the non-dominant or 
dominant arm with (52.5% vs. 47.5%, p=0.789; Online Resource 2, Table 1).  
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The results of the FRAX estimates of 10-year fracture risk are given in Table 2. Prior to the 
inclusion of lowest femoral neck BMD or fracture there was no significant difference 
between the two groups. This became significantly different with higher risk estimates in the 
fracture group once BMD or fracture or both were included in the calculation. Using FRAX 
calculated after inclusion of fracture and femoral neck BMD 13 participants (21%) in the 
fracture group compared to no participants in the control group were above NOGG treatment 
thresholds and would require treatment based on their fracture risk.  
 
Blood results 
The results of biochemical and haematological laboratory investigations are shown in Table 2 
of Online Resource 2. The only significant difference between the two groups was that the 
mean serum 25OHD concentration was higher in the fracture group compared with the 
control group (66.9 nmol/l vs. 53.0 nmol/l, p=0.003). This difference lost significance once 
adjustment for season in which the blood samples were taken had been made. There was no 
statistically significant difference between the groups when comparing vitamin D status 
(sufficient, insufficient, deficient) (X2=3.512, N=118, p=0.173). Of note, there was no 
significant difference between the groups in PTH, renal function, alkaline phosphatase, 
adjusted calcium, oestradiol or testosterone.  
 
Bone Mineral Density  
There was significantly lower BMD at all sites in the fracture group compared with the 
control group except at non-dominant distal 1/3 forearm and the distal 1/3 forearm (Table 3). 
Notably, there was significantly lower BMD at the ultradistal forearm (both dominant and 
non-dominant arm) and distal 1/3 forearm (dominant arm only) in the fracture subjects 
compared with control subjects. Interestingly, there was no difference in BMD between the 
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dominant and non-dominant forearm in the control subjects at the ultradistal radius (p=0.304) 
and the distal 1/3 radius (p=0.080). At those sites where BMD was significantly lower the 
percentage reduction in the fracture group compared with controls varied between 5.1% and 
11.5%, with greatest reduction being seen at the ultradistal forearm sites. As a result of the 
lower BMD the T- and Z-scores of these men (using male normative data) were significantly 
lower in the fracture subjects versus the control subjects as shown in Table 3 of Online 
Resource 2.  
Using male normative data 11.5% per cent were found to be osteoporotic at the lumbar spine 
or hip sites in the fracture group and 5.1% in the control group (Fisher’s Exact, p=0.324). 
This rises to 13.1% and 5.1% respectively if forearm sites are included (X2=2.236, N=119, 
p=0.206). At the femoral neck alone these figures are 11.5% and 3.4% (Fisher’s Exact, 
p=0.164). These differences were not statistically significant. 
Using female reference data at the femoral neck to define osteoporosis [20] reduces the 
proportion of osteoporotic participants to just 3.3% in the fracture group and zero in the 
control group. 
BMD at multiple sites was found to associate with: age, height and weight; adjusted calcium 
with the dominant ultradistal and both dominant and non-dominant distal 1/3 forearm, 
bioavailable oestradiol with the non-dominant ultradistal forearm, total oestradiol with the 
distal 1/3 forearm and finally TSH with the hip sites (Online Resource 2, Table 4). The 
observed differences in BMD between the two groups persisted at all sites after making 
adjustments for these factors.  
 
Predictors of likelihood of fracture  
The following clinically relevant variables that were found to be statistically significantly 
different between the fracture and control group (Table 1, Online Resource 2 Table 2) were 
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entered into a logistic regression analysis: Vitamin D, lumbar spine BMD, right femoral neck 
BMD, left femoral neck BMD, right total hip BMD, left total hip BMD, ultradistal and distal 
1/3 forearm BMD. Vitamin D was adjusted for seasons and adjusted values entered into the 
regression model. Only ultradistal forearm BMD remained as a significant variable in the 
final model. The regression analysis (Table 4) shows that the likelihood of fracture was 
decreased by 12.9% for every 0.01g/cm2 increase in ultradistal BMD. 
 
Predictors of BMD  
In order to determine the best predictors of BMD in all subjects, linear regression models 
were fitted with independent variables selected by forward selection for each individual site. 
Age, height and weight were seen as potentially predictive at all sites and were entered in all 
models. Further significantly correlated factors relevant to each site (Online Resource 2, 
Table 4) were added into the model relevant for the individual sites (Table 5).  
The best fitting model at the lumbar spine BMD accounted for 5.5% of the variation and 
incorporated height and total oestradiol. For the right femoral neck the model included weight 
and TSH and explained 8.9% of the variation, whereas at the left femoral neck 13.8% was 
accounted for by a model incorporating age and height. At both total hip sites only weight 
was predictive producing model that explained 5.8% of the right and 5.2% of the left BMD. 
At the ultradistal forearm the best model used bioavailable oestradiol and adjusted calcium to 
predict 7.8% of BMD and at the distal one third this was height, age and adjusted calcium to 
account for 23.7% of the variance.  
 
Discussion  
This is the first study to examine forearm BMD in men with distal forearm fracture, finding 
significantly lower BMD in fracture subjects at the ultradistal and distal 1/3 of the non-
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fractured forearm compared with the forearm BMD in control subjects. Regression analysis 
also showed that the likelihood of fracture decreases as BMD at this site increases. These 
findings are consistent with the study hypothesis and emphasise the importance of regional 
BMD in the pathogenesis if these fractures. Similar findings were reported in a study by Farr 
et al. [22], which showed that already in childhood and adolescence boys with low-trauma 
distal forearm fracture had skeletal deficits compared to control subjects.  
As in previous studies BMD was also significantly lower at all sites at the hip and spine or 
the heel compared with age and gender matched control subjects [8, 9, 23, 24]. The 
significantly lower areal BMD persisted after adjustment for confounders. This suggests a 
higher future fracture risk at all sites, which Cuddihy et al. [7] confirmed with a 2.7 fold and 
10.7 fold increased risk for hip and vertebral fractures respectively after a distal forearm 
fracture compared with age-matched men. Lower femoral neck BMD has also been identified 
as a risk factor for wrist fractures in an epidemiological study by Nguyen et al [25]. 
The greatest percentage reduction in BMD compared with controls was at the ultradistal site, 
which has previously only been observed in women with forearm fractures [26]. In men with 
vertebral fractures and hip fractures the greatest percentage reduction in BMD was observed 
at the lumbar spine and hip sites respectively [27, 28] and lumbar spine and hip BMD were 
the best predictors for fractures at these sites [28, 29]. This suggests that an element of 
regional bone loss may be contributing to the site of fracture occurrence. Furthermore, in 
control subjects there was no difference in BMD between the dominant and non-dominant 
forearm. This might explain why the men were equally likely to fracture the dominant or non-
dominant forearm. By contrast, in women, lower BMD has been reported in the non-
dominant forearm [30-32] and this difference has been hypothesised to explain why women 
are more likely to fracture the non-dominant arm.  
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Using male normative data the proportion of men with osteoporosis in at least one site 
(lumbar spine, femoral neck or total hip) was 11.5%, which rises to 13.1% if the forearms are 
included. This is much lower than the 42% seen previously by Tuck et al. [8] and the 23.3% 
found by Egund et al. in men over 65 years [9]. In the current study participants had very few 
medical problems or secondary causes (Table 1) and there were no differences between the 
groups. In contrast, Tuck et al. [8] and Egund et al. [9] found that up to 51% of subjects with 
forearm fractures and up to 37% of control subjects had secondary causes. Tuck et al. further 
reported a higher incidence of previous adult low trauma fracture with 47% in the fracture 
and 45% in the control group compared to 11.5% and 3.4% in our study cohort [8].  
Overall predictors of BMD varied with different sites and included: age, height, weight, 
adjusted calcium, TSH and oestradiol. This is consistent with previously published studies [8, 
27, 28]. The association between BMD and TSH has had conflicting results [33, 34], 
although Grimes et al. [33] found that men with very low TSH had low forearm BMD and 
argued that TSH may have bone protective properties. In the present study the strongest 
predictors of forearm BMD were bioavailable oestradiol and adjusted calcium for the 
ultradistal forearm and age, height and adjusted calcium for the distal 1/3 forearm. There was 
no association with TSH.  
Interestingly, in our study population there was no difference in 10-year predicted fracture 
risk as calculated by FRAX until BMD and/or the fracture were included. It would therefore 
have not been possible to identify these male subjects as at risk prior to fracture during 
routine screening. FRAX is well validated for predicting major and hip fractures in both 
genders [35-39], but major fractures are all grouped together [12, 13] as there were too few 
fractures of any one type to develop an algorithm for them individually. The European 
Osteoporosis Study looked at Colle’s fractures separately, but was unable to find any 
predictors for forearm fractures in men [39].  
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The strengths of the study are that the cohorts are very clearly defined by stringent inclusion 
criteria and there are very few confounders that could affect the outcomes. Subjects in 
fracture and control group were well and there are very few differences between the groups 
identified by questionnaire or blood tests. Study investigations have been carried out by the 
same individuals throughout the study, ensuring consistent data collection with accurate 
timing of follow-up assessments and taking of blood samples.  
A limitation of this study is its small sample size with only 59 fracture subjects. A larger 
study may identify further important factors in the pathogenesis of these fractures in men.  
However, the study was adequately powered to detect the observed differences in BMD and 
included more participants than other published comparative studies [23, 24]. 
case-control design, which introduces potential recall bias from participants. Also only 58% 
of eligible participants in the fracture and 61% in the control group agreed to take part in the 
study, resulting in possible selection bias. The most common reasons for not wishing to take 
part in the study were a lack of interest in research, inability to attend study appointments 
(particularly for subjects in work), travel distance to the appointment and the belief that the 
study did not apply to them. However, comparing data from participating subjects and 
subjects who only provided questionnaire data revealed no significant differences.  
Prior fragility fracture was an exclusion criterion for control but not fracture subjects, which 
could have potentially accentuated differences between the two groups. However, there were 
only 7 prior fragility fractures identified in the fracture group and 2 in the controls, a 
difference that was not statistically significant. Furthermore, the FRAX risk estimates were 
not significantly different between the two groups until BMD and/ or forearm fracture were 
added. It therefore seems unlikely that such a bias occurred.  
Participants in the fracture group may have altered their activity levels and use of the injured 
hand, which could have affected regional BMD. The lower score in the physical domain of 
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SF36v2, even though not clinically significant, could be an indicator of this. However, the 
non-fractured forearm was scanned, which may on the contrary have been used more to 
compensate for the loss of function in the fractured arm. In addition there was no difference 
between groups in the activity level captured during their falls risk assessment. BMD changes 
also occur slowly, so that BMD measurement three to six months after fracture are unlikely to 
detect a significant reduction in BMD given the relatively minor nature of the fracture. 
This study is the first to demonstrate significantly lower BMD at the forearm in fracture 
subjects compared with controls. The greatest percentage reduction in BMD compared with 
control subjects was at the ultradistal forearm and the best predictor of forearm fracture was 
ultradistal forearm BMD. FRAX could not identify these men at risk until they had fractured 
or had BMD measured so further factors may need to be found if these men are to be 
identified prior to fracture. We suggest that all men with low trauma distal forearm fractures 
should be considered at risk of osteoporosis and further fractures. Further work is required to 
understand their pathogenesis. 
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Supplementary Material: Details of laboratory assays 
 
U&E, bone profile, LFT, CRP and glucose were analysed on the Siemens automated Advia 
analysers (either Advia2400 or 1800) – Siemens Healthcare Diagnostics Inc. Sir William 
Siemens Sq. Frimley, Camberley UK. Intact parathyroid hormone (PTH) was measured in 
EDTA plasma on the Roche E411 analyser (Roche Diagnostics, Lewes, UK). The assay 
employs a Sandwich principle electro-chemiluminescence immunoassay (ECLIA). FBC (Full 
Blood Count) was measured using a Siemens Advia 120 analyser (Siemens Healthcare 
Diagnostics Inc. Sir William Siemens Sq. Frimley, Camberley UK) in EDTA whole blood. 
The ESR was measured in EDTA whole blood on the Starrsed Compact ESR analyser. This 
produces a true Westergren ESR result and therefore conforms to the recommendations of the 
International Council for Standardisation in Haematology (ICSH). The StaRRsed Compact 
ESR analyser is a fully automated analyser for the haematology laboratory made by 
Mechatronics Manufacturing BV in the Netherlands and marketed in the UK by: Vitech 
Scientific Ltd Huffwood Trading Estate Partridge Green West Sussex RH13 8AU. Total 
serum 25OHD was measured on an IDS-iSYS automated analyser (Immuno-Diagnostic 
Systems, Bolden, UK).  
Oestradiol (E2) was measured by electro-chemiluminescence immunoassay (ECLIA) on the 
automated COBAS e601 system (Roche Diagnostics, Mannheim, Germany). The inter-assay 
CV was ≤1.5% between 18.4-15781 pmol/L with lower detection limit of 18.4 pmol/L. 
Testosterone measurement was carried out via LC-MS/MS analysis using a SCIEX API4000 
mass spectrometry instrument coupled to an atmospheric pressure chemical ionization 
(APCI) source (Warrington, UK) with a Shimadzu Prominence UFLC XR LC-20AD HPLC 
system (Duisburg, Germany). The LC-MS/MS raw data were processed using Analyst 
software (version 1.5.1, SCIEX).  
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Bioavailable oestradiol (Bio-E2) and testosterone (Bio-T) were measured indirectly using a 
radioimmunoassay. Samples (400µL) were stripped of all steroids using activated charcoal 
(400µL of a 5% solution in phosphate buffer 1M pH 7.4). Charcoal stripped serum (200µL) was 
added to nitrogen-dried tritiated 3H-testosterone or 3H-oestradiol (20,000Dpm/50µL, Perkin-
Elmer, Beaconsfield, UK) and incubated for 2hr at 37°C to allow binding with SHBG. The 
SHBG-bound 3H-testosterone or 3H-oestradiol were then precipitated using 200 µL of an ice-
cold saturated solution of ammonium sulphate.  A control tube (blank) containing 200 µL NaCl 
0.9% was treated with each tritiated standard. The precipitated samples and controls were 
centrifuged at 4°C for 20 minutes at 3,500 x g. 200 µL of the supernatant containing the non-
SHBG bound 3H-testosterone or 3H-oestradiol fractions were transferred to a scintillation vial. 
3mL of scintillation liquid (OptiPhase, HiSafe-3, Perkin-Elmer) was added to each tube. Beta 
radiation activity was measured on a Hidex 300SL automatic scintillation counter (Turku, 
Finland) for 2 minutes per tube. The radioactivity ratio of the SHBG-unbound/bound fractions 
were expressed in percentage using the equation: 
%𝐵𝑖𝑜 − 𝑇 (𝑜𝑟 𝐸2) =
𝑎𝑣𝑒𝑟𝑎𝑔𝑒(𝑠𝑎𝑚𝑝𝑙𝑒 𝑐𝑜𝑢𝑛𝑡𝑠)
𝑏𝑙𝑎𝑛𝑘 (𝑁𝑎𝐶𝑙 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
∗ 100 
Concentrations of bioavailable testosterone and bioavailable oestradiol were given in nmol/L 
using   𝐵𝑖𝑜 − 𝑇(𝑜𝑟 𝐸2) = 𝑡𝑜𝑡𝑎𝑙(𝑇 𝑜𝑟 𝐸2) ∗ %𝐵𝑖𝑜 − 𝑇 (𝑜𝑟 𝐸2) 
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Supplementary Table 1: Site of forearm fracture by hand dominance. 
 Right hand dominant Left hand dominant  
Fracture dominant FA 23 (37.7%) 6 (9.3%) 29 (47.5%) 
Fracture non-dominant FA 31 (50.8%) 1 (1.6%) 32 (52.5%) 
 54 (88.5%) 7 (11.5%) 61 (100%) 
 
FA=forearm 
 
 
 
Supplementary Table 2: Blood results and male reference ranges over 50 years.  
 
Investigation (reference range)  Fracture 
(n=61) 
Control 
(n=59) 
p-value 
Hb g/L (13.0-18.0) 14.49 (1.17) 14.71 (1.13) 0.316+ 
WBC x109/L (4-11) 6.10 (1.76) 5.69 (1.35) 0.164+ 
Platelets x109/L (150-400) 254.41 (75.98) 237.00 (66.47) 0.188+ 
ESR mm/hr (2-10) 7.48 (10.33) 8.33 (16.60) 0.883* 
Sodium mmol/L (133-146) 140.41 (1.67) 139.66 (2.04) 0.032+ 
Potassium mom/L (3.5-5.3) 4.21 (0.32) 4.28 (0.21) 0.128+ 
Creatinine µmol/L (50-120) 86.69 (12.85) 84.90 (14.08) 0.410* 
Bilirubin µmol/L (0-21) 11.80 (5.52) 13.19 (4.77) 0.146+ 
Protein g/L (60-80) 71.39 (4.50) 71.95 (4.68) 0.509+ 
Albumin g/L (35-50) 43.81 (2.61) 43.39 (2.41) 0.362+ 
ALP U/L (30-130) 75.73 (19.31) 72.54 (16.38) 0.336+ 
ALT U/L (1-40) 27.39 (11.54) 26.16 (12.14) 0.412* 
GGT U/L (0-70) 36.32 (29.74) 33.98 (23.59) 0.579* 
Phosphate mmol/L (0.8-1.5) 1.01 (0.12) 1.00 (0.13) 0.647+ 
Adjusted calcium mmol/L (2.2-2.6) 2.32 (0.09) 2.32 (0.08) 0.700+ 
Glucose mmol/L (2.2-6.0) 5.59 (1.01) 5.59 (1.18) 0.967& 
TSH mU/L (0.27-4.2) 2.05 (1.18) 2.06 (0.99) 0.524* 
PTH ng/L (12-72) 48.37 (18.00) 51.13 (21.41) 0.776* 
Vitamin D (nmol/L)  66.88 (27.58) 53.00 (21.27) 0.003+ 
Vitamin D seasonally adjusted 1.06 (0.41) 0.94 (0.38) 0.091+ 
Oestradiol (pmol/L) 98.34 (28.25) 105.28 (30.24) 0.202+ 
Bio-Oestradiol (pmol/L) 18.85 (7.30) 17.87 (5.46) 0.411+ 
Testosterone (nmol/L) 15.00 (5.19) 16.67 (5.33) 0.089+ 
Bio-Testosterone (nmol/L) 2.66 (0.98) 2.58 (0.91) 0.677+ 
 
Blood investigations - mean and SD; + t-test; * t-test on log-transformed data; & Mann-Whitney U Test 
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Supplementary Table 3: Comparison of T- and Z-Scores – mean and SD. 
Site  Fracture Control p-Value 
AP Spine L2-4 T-score 
Z-score 
-0.389 (1.467) 
-0.097 (1.408) 
0.289 (1.731) 
0.620 (1.862) 
0.023 
0.019 
Right femoral neck T-score 
Z-score 
-1.241 (0.878) 
-0.262 (0.749) 
-0.766 (0.948) 
0.253 (0.944) 
0.006 
0.001 
Left femoral neck T-score 
Z-score 
-1.368 (1.009) 
-0.395 (0.866) 
-0.840 (1.060) 
0.197 (1.021) 
0.006 
0.001 
Right total femur T-score 
Z-score 
-0.826 (0.960) 
-0.184 (0.841) 
-0.262 (0.981) 
0.424 (1.037) 
0.002 
0.001 
Left total femur T-score 
Z-score 
-1.162 (0.994) 
-0.261 (0.911) 
-0.309 (1.018) 
0.374 (1.002) 
0.002 
<0.001 
Dominant ultradistal FA T-score 
Z-score 
-0.916 (1.205) 
-0.258 (1.200) 
0.297 (1.315) 
0.953 (1.348) 
<0.001 
<0.001 
Nondominant ultradistal FA T-score 
Z-score 
-0.900 (1.442) 
-0.400 (1.437) 
0.195 (1.477) 
0.866 (1.470) 
0.001 
0.004 
Dominant distal 1/3 FA T-score 
Z-score 
-0.794 (0.826) 
-0.126 (0.784) 
-0.305 (0.808) 
0.371 (0.755) 
0.008 
<0.001 
Nondominant distal 1/3 FA T-score 
Z-score 
-0.703 (0.785) 
-0.193 (0.761) 
-0.417 (0.760) 
0.261 (0.738) 
0.100 
0.008 
 
FA=forearm 
Reference population for lumbar spine and forearm sites: manufacturer’s reference ranges for males 
Reference population for hip sites: NHANES III reference for males 20-39 years of age 
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Supplementary Table 4: Correlation between BMD and clinically relevant variables. 
 
BMD Age Height Weight Crea adjCa TSH PTH VitD E2 Bio-E2 T Bio-T 
L24 0.196 
p=0.032 
0.134 
p=0.143 
0.124 
p=0.176 
0.158 
p=0.087 
-0.025 
p=0.789 
0.059 
p=0.523 
0.040 
p=0.668 
-0.082 
p=0.377 
0.190 
p=0.040 
0.095 
p=0.306 
-0.08 
p=0.932 
-0.043 
p=0.648 
RFN -0.197 
p=0.034 
0.251 
p=0.007 
0.269 
p=0.004 
0.065 
p=0.492 
-0.112 
p=0.236 
0.223 
p=0.017 
-0.054 
p=0.571 
0.051 
p=0.595 
0.080 
p=0.398 
0.081 
p=0.392 
0.006 
p=0.945 
0.071 
p=0.452 
LFN -0.325 
p<0.001 
0.290 
p=0.001 
0.247 
p=0.007 
0.011 
p=0.904 
-0.124 
p=0.184 
0.202 
p=0.030 
-0.031 
p=0.740 
0.002 
p=0.983 
0.017 
p=0.854 
0.056 
p=0.550 
-0.017 
p=0.859 
0.082 
p=0.383 
RTH -0.112 
p=0.232 
0.111 
p=0.237 
0.257 
p=0.005 
0.097 
p=0.303 
-0.146 
p=0.121 
0.195 
p=0.038 
-0.019 
p=0.840 
-0.003 
p=0.975 
0.113 
p=0.233 
0.146 
p=0.122 
-0.061 
p=0.516 
0.000 
p=0.997 
LTH -0.195 
p=0.034 
0.185 
p=0.045 
0.246 
p=0.007 
0.051 
p=0.589 
-0.143 
0.126 
0.193 
p=0.037 
-0.004 
p=0.969 
0.014 
p=0.882 
0.081 
p=0.390 
0.115 
p=0.221 
-0.022 
p=0.813 
0.072 
p=0.441 
DUDFA -0.076 
p=0.478 
0.154 
p=0.148 
0.173 
p=0.103 
-0.026 
p=0.810 
-0.228 
p=0.032 
0.120 
p=0.263 
0.027 
p=0.799 
-0.078 
p=0.469 
0.066 
p=0.542 
0.134 
p=0.214 
0.091 
p=0.398 
0.167 
p=0.119 
NDUDFA -0.032 
p=0.766 
-0.001 
p=0.993 
0.150 
p=0.161 
-0.066 
p=0.540 
-0.160 
p=0.137 
0.026 
p=0.811 
-0.104 
p=0.337 
0.041 
p=0.707 
0.142 
p=0.189 
0.285 
p=0.007 
-0.066 
p=0.539 
-0.011 
p=0.918 
D33FA -0.307 
p=0.003 
0.401 
p=0.003 
0.309 
p=0.003 
0.014 
p=0.897 
-0.250 
p=0.018 
0.073 
p=0.496 
-0.021 
p=0.843 
-0.097 
p=0.367 
-0.270 
p=0.011 
-0.047 
p=0.661 
-0.122 
p=0.256 
0.048 
p=0.655 
ND33FA -0.225 
p=0.035 
0.377 
p<0.001 
0.256 
p=0.016 
0.011 
p=0.920 
-0.234 
p=0.029 
0.082 
p=0.449 
-0.139 
p=0.200 
0.164 
p=0.131 
-0.128 
0.241 
0.065 
p=0.555 
-0.061 
p=0.574 
-0.057 
p=0.602 
FAUD -0.074 
p=0.420 
0.086 
p=0.249 
0.209 
p=0.022 
-0.075 
p=0.417 
-0.176 
p=0.057 
0.075 
p=0.421 
-0.053 
p=0.570 
0.018 
p=0.845 
0.112 
p=0.228 
0.236 
p=0.010 
-0.019 
p=0.842 
0.056 
p=0.545 
FA33 -0.302 
p=0.001 
0.400 
p<0.001 
0.319 
p<0.001 
0.016 
p=0.863 
-0.247 
p=0.007 
0.131 
p=0.161 
-0.084 
p=0.367 
0.108 
p=0.248 
-0.184 
p=0.047 
0.030 
p=0.748 
-0.103 
p=0.265 
0.019 
p=0.841 
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Pearson Correlation coefficient; L24=lumbar spine L2-4, RFN=right femoral neck, LFN=left femoral neck, RTH=right total femur, LTH=left total femur, DUDFA=dominant 
ultradistal forearm, NDUDFA=non-dominant ultradistal forearm, D33FA=dominant distal 1/3 forearm, ND33FA=non-dominant distal 1/3 forearm, FAUD= ultradistal 
forearm, FA33= distal 1/3 forearm, Crea=Creatinine, adjCa=adjusted Calcium, TSH=thyroid stimulating hormone, PTH=parathyroid hormone, VitD= 25 hydroxyvitamin D, 
E2=Oestradiol, Bio-E2=bioavailable Oestradiol, T=Testosterone, Bio-T=bioavailable Testosterone 
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